Riverside Partners Named to Inc.'s 2025 List of Founder-Friendly Investors

Annual roundup highlights the private equity firms, venture capital firms, and lenders with track records of backing founder-led companies

BOSTON, Oct. 28, 2025 /PRNewswire/ -- Riverside Partners, a Boston-based private equity firm focused on the healthcare and technology sectors, today announced it has been recognized as an Inc. 2025 Founder-Friendly Investor. Inc.'s list honors private investment firms with a track record of backing founder-owned businesses. This is the fifth consecutive year Riverside Partners has been named to this list.

The list, which was published on October 28^th, recognizes firms that founders and entrepreneurs view as collaborative and trustworthy as they receive the financial support they need to help drive growth. The firms on Inc.'s list have successful track records of remaining actively involved with their portfolio businesses.

"Raising capital is no small feat for today's entrepreneurs. That's why discovering investors who offer more than just financial backing—those who bring mentorship, resources, and a true spirit of partnership to your growth journey—is both rare and invaluable," says Bonny Ghosh, editorial director at Inc. "The 2025 Founder-Friendly Investors are collaborators and dedicated to helping their portfolio companies succeed."

David Belluck, a General Partner at Riverside Partners, commented on the award saying, "It's an honor to be recognized as an Inc. 2025 Founder-Friendly Investor. The award is a tribute to our longstanding commitment to partnering with founders to meet their goals for themselves and their businesses, and to help them accelerate the growth of their companies. For over 35 years, we have been investing in founder-owned healthcare and technology businesses. The founders we team with retain significant equity, play a meaningful role going forward, and care deeply about their employees. We are proud to build close relationships with them based on a high degree of trust, alignment, and collaboration and to provide additional resources to further build their businesses."

In commenting on his experience partnering with Riverside Partners, Dr. Prabu Nambiar, founder of Syner-G BioPharma Group, a current portfolio company of Riverside, said the following, "I selected Riverside as my partner because of their sector expertise and value-added approach to building companies - I could not be more pleased with my choice. Riverside has collaborated with me and the Syner-G team to grow the company significantly while respecting our culture and values. The Riverside team has provided deep expertise, meaningful operational and strategic support, valuable introductions to customers, and significant investment for expansion – both organically and through acquisition. Throughout our business building journey, they have been excellent partners demonstrating collaboration, support, and alignment every step of the way."

Introduced in 2019, the Founder-Friendly Investors list quickly established itself as one of Inc.'s most resourceful franchises. It has become a go-to guide for entrepreneurs who want to grow their companies while retaining an ownership stake.

To see the complete list, go to: https://www.inc.com/founder-friendly-investors.

About Inc.
Inc. is the leading media brand and playbook for the entrepreneurs and business leaders shaping our future. Through its journalism, Inc. aims to inform, educate, and elevate the profile of its community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating the future of business. Inc. is published by Mansueto Ventures LLC, along with fellow leading business publication Fast Company. For more information, visit www.inc.com.

About Riverside Partners
Founded in 1989, Riverside Partners is a middle market private equity firm with total capital commitments of $1.6 billion raised since inception. The firm focuses on growth-oriented companies in the healthcare and technology industries. Riverside Partners is particularly experienced at partnering with founders, owners, and management teams and brings substantial domain expertise and operating experience to its portfolio companies. For more information, visit www.riversidepartners.com.

Legal Disclosure
Industry recognitions or awards should not be construed as an endorsement or a recommendation to retain the Adviser by the ranking entity or any regulatory authority. Any rankings or awards cited were provided by independent third parties based on their predetermined evaluation criteria. Although Adviser provided compensation to the ranking entity to be included in the survey, it did not exercise any influence or control over the criteria used or the results generated, other than providing or making available, directly or indirectly, objective numerical data that could have been used by third-party as input variables. Statement by Dr. Prabu Nambiar is an endorsement made by an executive of a portfolio company invested in by Adviser. No direct or indirect compensation has been provided for such statements. 

SOURCE Riverside Partners